JY
XGN icon

Jeff Yass’s Exagen XGN Stock Holding History

Jeff Yass’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-71,000
Closed -$170K – 13604
2022
Q4 		$170K Sell
71,000
-11,000
-13% -$28.2K ﹤0.01% 10347
2022
Q3 		$222K Sell
82,000
-52,400
-39% -$292K ﹤0.01% 10574
2022
Q2 		$771K Buy
134,400
+13,100
+11% +$76.3K ﹤0.01% 7172
2022
Q1 		$974K Buy
+121,300
New +$1.05M ﹤0.01% 7190

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Jeff Yass's XGN Position: Q2 2026 in Review

Jeff Yass sold out of Exagen (XGN) in Q2 2026, closing a stake of 25,476 shares — an estimated $76.4K sold.

Jeff Yass first reported a position in XGN in Q2 2022 and held it in 4 quarters. The position peaked at $2.22M in Q3 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Jeff Yass reported no remaining Exagen position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 25,476 Exagen shares in Q2 2026, an estimated $76.4K.
  • Jeff Yass first reported a position in Exagen in Q2 2022 and held it in 4 quarters.
  • Jeff Yass's Exagen position peaked at $2.22M in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.